---
title: <em>Plasmodium falciparum</em> merozoite surface protein 1 as asexual blood
  stage malaria vaccine candidate
date: '2023-12-15'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38100310/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20231216170650&v=2.18.0
source: heidelberg[Affiliation]
description: 'INTRODUCTION: Malaria represents a tremendous public health challenge
  in tropical and sub-tropical regions, and currently deployed control strategies
  are likely insufficient to drive elimination of malaria. Development and improvement
  of malaria vaccines might be key to reduce disease burden. Vaccines targeting asexual
  blood stages of the parasite have shown limited efficacy when studied in human trials
  conducted over the past ...'
disable_comments: true
---
INTRODUCTION: Malaria represents a tremendous public health challenge in tropical and sub-tropical regions, and currently deployed control strategies are likely insufficient to drive elimination of malaria. Development and improvement of malaria vaccines might be key to reduce disease burden. Vaccines targeting asexual blood stages of the parasite have shown limited efficacy when studied in human trials conducted over the past ...